`

Apollomics

Biotechnology Research

Specialities :
Oncology
Cancer immunotherapy
Targeted therapies
Monoclonal antibodies
And clinical trials
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$23.65M
size-icon Size
11 - 50

Frequently Asked Questions About Apollomics

What does Apollomics do?+

Apollomics is an innovative biotechnology company committed to the discovery and development of oncology combination therapies. With operations in both the U.S. and China, we believe we are well positioned to unlock synergies by leveraging the strengths of partnerships with other biotechnology companies in the East and the West. Since our founding in 2015, under the leadership of our experienced management team with in-depth knowledge and expertise of the evolving cancer treatment landscape, we have built a pipeline of ten (10) drug candidates across 12 programs that focus on oncology, of which five (5) drug candidates are at clinical stage....

What are Apollomics's specialties? +

Oncology,cancer immunotherapy,targeted therapies,monoclonal antibodies,and clinical trials

What is Apollomics's industry? +

Apollomics operates in the Biotechnology research industry.

What is Apollomics's revenue? +

Apollomics's revenue is 11m - 100m

What is Apollomics's company size? +

Apollomics has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.